相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。MiR-140 leads to MRE11 downregulation and ameliorates oxaliplatin treatment and therapy response in colorectal cancer patients
Josef Horak et al.
FRONTIERS IN ONCOLOGY (2022)
Human CtIP: A ?double agent? in DNA repair and tumorigenesis
Nour L. Mozaffari et al.
SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY (2021)
Telomeres: history, health, and hallmarks of aging
Deepavali Chakravarti et al.
CELL (2021)
A predictive signature for oxaliplatin and 5-fluorouracil based chemotherapy in locally advanced gastric cancer
Qinchuan Wang et al.
TRANSLATIONAL ONCOLOGY (2021)
A Role for Human DNA Polymerase λ in Alternative Lengthening of Telomeres
Elisa Mentegari et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
Twelve years of SAMtools and BCFtools
Petr Danecek et al.
GIGASCIENCE (2021)
Involvement of ATMIN-DYNLL1-MRN axis in the progression and aggressiveness of serous ovarian cancer
Caglar Berkel et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2021)
5-fluorouracil and other fluoropyrimidines in colorectal cancer: Past, present and future
Sona Vodenkova et al.
PHARMACOLOGY & THERAPEUTICS (2020)
Role of common ERCC1 polymorphisms in cisplatin-resistant epithelial ovarian cancer patients: A study in Chinese cohort
Yuxia Bao et al.
INTERNATIONAL JOURNAL OF IMMUNOGENETICS (2020)
The mutational constraint spectrum quantified from variation in 141,456 humans
Konrad J. Karczewski et al.
NATURE (2020)
DNA Repair and Ovarian Carcinogenesis: Impact on Risk, Prognosis and Therapy Outcome
Kristyna Tomasova et al.
CANCERS (2020)
PARP Inhibitors in the Management of Ovarian Cancer: ASCO Guideline
William P. Tew et al.
JOURNAL OF CLINICAL ONCOLOGY (2020)
First-line PARP inhibitors in ovarian cancer: summary of an ESMO Open - Cancer Horizons round-table discussion
Susana Banerjee et al.
ESMO OPEN (2020)
RAD50 deficiency is a predictor of platinum sensitivity in sporadic epithelial ovarian cancers
Adel Alblihy et al.
MOLECULAR BIOMEDICINE (2020)
High-Grade Serous Ovarian Cancer: Basic Sciences, Clinical and Therapeutic Standpoints
Michael-Antony Lisio et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
PARP inhibitors in ovarian cancer: Sensitivity prediction and resistance mechanisms
Xuan Jiang et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2019)
Identification of a Prognostic Signature Associated With DNA Repair Genes in Ovarian Cancer
Hengzi Sun et al.
FRONTIERS IN GENETICS (2019)
DNA repair capacity and response to treatment of colon cancer
Pavel Vodicka et al.
PHARMACOGENOMICS (2019)
Hypermethylation of mismatch repair gene hMSH2 associates with platinum-resistant disease in epithelial ovarian cancer
Hua Tian et al.
CLINICAL EPIGENETICS (2019)
Estimating the global cancer incidence and mortality in 2018: GLOBOCAN sources and methods
J. Ferlay et al.
INTERNATIONAL JOURNAL OF CANCER (2019)
Association of MGMT promoter methylation with tumorigenesis features in patients with ovarian cancer: A systematic meta-analysis
Baoli Qiao et al.
MOLECULAR GENETICS & GENOMIC MEDICINE (2018)
fastp: an ultra-fast all-in-one FASTQ preprocessor
Shifu Chen et al.
BIOINFORMATICS (2018)
The association of polymorphisms in nucleotide excision repair genes with ovarian cancer susceptibility
Zhiguang Zhao et al.
BIOSCIENCE REPORTS (2018)
Converging endometrial and ovarian tumorigenesis in Lynch syndrome: Shared origin of synchronous carcinomas
Anni Niskakoski et al.
GYNECOLOGIC ONCOLOGY (2018)
RAD50 germline mutations are associated with poor survival in BRCA1/2-negative breast cancer patients
Cong Fan et al.
INTERNATIONAL JOURNAL OF CANCER (2018)
Bioconda: sustainable and comprehensive software distribution for the life sciences
Bjoern Gruening et al.
NATURE METHODS (2018)
Promoter methylation of DNA damage repair (DDR) genes in human tumor entities: RBBP8/CtIP is almost exclusively methylated in bladder cancer
Jolein Mijnes et al.
CLINICAL EPIGENETICS (2018)
Maftools: efficient and comprehensive analysis of somatic variants in cancer
Anand Mayakonda et al.
GENOME RESEARCH (2018)
Role of BRCA Mutations in Cancer Treatment with Poly(ADP-ribose) Polymerase (PARP) Inhibitors
Isabella Faraoni et al.
CANCERS (2018)
Prevalence of Homologous Recombination-Related Gene Mutations Across Multiple Cancer Types
Arielle L. Heeke et al.
JCO PRECISION ONCOLOGY (2018)
Prognostic values of DNA mismatch repair genes in ovarian cancer patients treated with platinum-based chemotherapy
Chuchu Zhao et al.
ARCHIVES OF GYNECOLOGY AND OBSTETRICS (2018)
Advances in ovarian cancer therapy
Alexander J. Cortez et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2018)
Preprocessing, normalization and integration of the Illumina HumanMethylationEPIC array with minfi
Jean-Philippe Fortin et al.
BIOINFORMATICS (2017)
Worldwide comparison of ovarian cancer survival: Histological group and stage at diagnosis (CONCORD-2)
Melissa Matz et al.
GYNECOLOGIC ONCOLOGY (2017)
PRKDC regulates chemosensitivity and is a potential prognostic and predictive marker of response to adjuvant chemotherapy in breast cancer patients
Gang Sun et al.
ONCOLOGY REPORTS (2017)
Living on the Edge: DNA Polymerase Lambda between Genome Stability and Mutagenesis
Barbara van Loon et al.
CHEMICAL RESEARCH IN TOXICOLOGY (2017)
PARP Inhibitors in Reproductive System Cancers: Current Use and Developments
Geraldine O'Sullivan Coyne et al.
DRUGS (2017)
Lack of MRE11-RAD50-NBS1 (MRN) complex detection occurs frequently in low-grade epithelial ovarian cancer
Simone Brandt et al.
BMC CANCER (2017)
Qualimap 2: advanced multi-sample quality control for high-throughput sequencing data
Konstantin Okonechnikov et al.
BIOINFORMATICS (2016)
hPso4/hPrp19: a critical component of DNA repair and DNA damage checkpoint complexes
K. Mahajan
ONCOGENE (2016)
Expression of DNA double-strand break repair proteins predicts the response and prognosis of colorectal cancer patients undergoing oxaliplatin-based chemotherapy
Keisuke Ihara et al.
ONCOLOGY REPORTS (2016)
Double-strand break repair and colorectal cancer: gene variants within 3′ UTRs and microRNAs binding as modulators of cancer risk and clinical outcome
Alessio Naccarati et al.
ONCOTARGET (2016)
Hereditary cancer syndromes: utilizing DNA repair deficiency as therapeutic target
Gaurav Goyal et al.
FAMILIAL CANCER (2016)
Copy number deletion of RAD50 as predictive marker of BRCAness and PARP inhibitor response in BRCA wild type ovarian cancer
Min Zhang et al.
GYNECOLOGIC ONCOLOGY (2016)
Molecular Characterization of Epithelial Ovarian Cancer: Implications for Diagnosis and Treatment
Veronica Rojas et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2016)
Near-optimal probabilistic RNA-seq quantification
Nicolas L. Bray et al.
NATURE BIOTECHNOLOGY (2016)
Biomarker analysis of the MITO2 phase III trial of first-line treatment in ovarian cancer: predictive value of DNA-PK and phosphorylated ACC
Francesco Perrone et al.
ONCOTARGET (2016)
Ovarian cancer
Ursula A. Matulonis et al.
NATURE REVIEWS DISEASE PRIMERS (2016)
Single Gene Prognostic Biomarkers in Ovarian Cancer: A Meta-Analysis
Scooter Willis et al.
PLOS ONE (2016)
Critical evaluation of the Illumina MethylationEPIC BeadChip microarray for whole-genome DNA methylation profiling
Ruth Pidsley et al.
GENOME BIOLOGY (2016)
Hereditary breast and ovarian cancer: new genes in confined pathways
Finn Cilius Nielsen et al.
NATURE REVIEWS CANCER (2016)
Contribution of Germline Mutations in the RAD51B, RAD51C, and RAD51D Genes to Ovarian Cancer in the Population
Honglin Song et al.
JOURNAL OF CLINICAL ONCOLOGY (2015)
Orchestrating high-throughput genomic analysis with Bioconductor
Wolfgang Huber et al.
NATURE METHODS (2015)
limma powers differential expression analyses for RNA-sequencing and microarray studies
Matthew E. Ritchie et al.
NUCLEIC ACIDS RESEARCH (2015)
Germline and Somatic Mutations in Homologous Recombination Genes Predict Platinum Response and Survival in Ovarian, Fallopian Tube, and Peritoneal Carcinomas
Kathryn P. Pennington et al.
CLINICAL CANCER RESEARCH (2014)
ATM, ATR and DNA-PKcs expressions correlate to adverse clinical outcomes in epithelial ovarian cancers
Tarek M. A. Abdel-Fatah et al.
BBA CLINICAL (2014)
Genome-wide DNA methylation profiles in progression to in situ and invasive carcinoma of the breast with impact on gene transcription and prognosis
Thomas Fleischer et al.
GENOME BIOLOGY (2014)
Clinicopathological and functional significance of XRCC1 expression in ovarian cancer
Tarek Abdel-Fatah et al.
INTERNATIONAL JOURNAL OF CANCER (2013)
Silencing of human DNA polymerase λ causes replication stress and is synthetically lethal with an impaired S phase checkpoint
Elisa Zucca et al.
NUCLEIC ACIDS RESEARCH (2013)
Enhanced levels of double-strand DNA break repair proteins protect ovarian cancer cells against genotoxic stress-induced apoptosis
Rajkumar Singh Kalra et al.
JOURNAL OF OVARIAN RESEARCH (2013)
Xeroderma pigmentosum complementation group C single-nucleotide polymorphisms in the nucleotide excision repair pathway correlate with prolonged progression-free survival in advanced ovarian cancer
Nicole D. Fleming et al.
CANCER (2012)
Association Between BRCA1 and BRCA2 Mutations and Survival in Women With Invasive Epithelial Ovarian Cancer
Kelly L. Bolton et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2012)
Therapeutic strategies in epithelial ovarian cancer
Ayako Kim et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2012)
Differential expression analysis of multifactor RNA-Seq experiments with respect to biological variation
Davis J. McCarthy et al.
NUCLEIC ACIDS RESEARCH (2012)
Complete pipeline for Infinium® Human Methylation 450K BeadChip data processing using subset quantile normalization for accurate DNA methylation estimation
Nizar Touleimat et al.
EPIGENOMICS (2012)
SWAN: Subset-quantile Within Array Normalization for Illumina Infinium HumanMethylation450 BeadChips
Jovana Maksimovic et al.
GENOME BIOLOGY (2012)
The variant call format and VCFtools
Petr Danecek et al.
BIOINFORMATICS (2011)
Identification of potential pharmacogenomic markers of clinical efficacy of 5-fluorouracil in colorectal cancer
Stefania Nobili et al.
INTERNATIONAL JOURNAL OF CANCER (2011)
Association of BRCA1 and BRCA2 Mutations With Survival, Chemotherapy Sensitivity, and Gene Mutator Phenotype in Patients With Ovarian Cancer
Da Yang et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2011)
Integrated genomic analyses of ovarian carcinoma
D. Bell et al.
NATURE (2011)
A framework for variation discovery and genotyping using next-generation DNA sequencing data
Mark A. DePristo et al.
NATURE GENETICS (2011)
DNA-PK Mediates AKT Activation and Apoptosis Inhibition in Clinically Acquired Platinum Resistance
Euan A. Stronach et al.
NEOPLASIA (2011)
Comparison of Beta-value and M-value methods for quantifying methylation levels by microarray analysis
Pan Du et al.
BMC BIOINFORMATICS (2010)
The Genome Analysis Toolkit: A MapReduce framework for analyzing next-generation DNA sequencing data
Aaron McKenna et al.
GENOME RESEARCH (2010)
Fast and accurate short read alignment with Burrows-Wheeler transform
Heng Li et al.
BIOINFORMATICS (2009)
Functional complementation studies identify candidate genes and common genetic variants associated with ovarian cancer survival
Lydia Quaye et al.
HUMAN MOLECULAR GENETICS (2009)
DNA-Dependent Protein Kinase (DNA-PK)-Dependent Cisplatin-Induced Loss of Nucleolar Facilitator of Chromatin Transcription (FACT) and Regulation of Cisplatin Sensitivity by DNA-PK and FACT
Janna Dejmek et al.
MOLECULAR CANCER RESEARCH (2009)
Determinants of chemosensitivity in gastric cancer
David J. Park et al.
CURRENT OPINION IN PHARMACOLOGY (2006)
Mutation screening of Mre11 complex genes:: indication of RAD50 involvement in breast and ovarian cancer susceptibility -: art. no. e131
K Heikkinen et al.
JOURNAL OF MEDICAL GENETICS (2003)
5-Fluorouracil: Mechanisms of action and clinical strategies
DB Longley et al.
NATURE REVIEWS CANCER (2003)
BRCA2 is required for homology-directed repair of chromosomal breaks
ME Moynahan et al.
MOLECULAR CELL (2001)
分享论文
